Private equity firm Advent International (Advent) has signed a definitive agreement to acquire a majority interest in Bharat Serums and Vaccines Limited for an undisclosed sum. Bharat Serums is a biopharmaceutical player in women’s healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets. — Business Standard
AZB & Partners advised
2019-11-18
Deal value: Confidential
{incomplete}
Comments
No comments yet.